Johnson & Johnson
JNJ
$0.00 (0.00%)
1D
1W
3M
1Y
5Y
ALL
Johnson & Johnson is a holding company, which is engaged in the research and development, manufacture and sale of a range of products in the healthcare field. It operates through three segments: Consumer, Pharmaceutical and Medical Devices. Its primary focus is products related to human health and well-being. The Consumer segment includes a range of products used in the skin health/beauty, over-the-counter medicines, baby care, oral care, women’s health and wound care markets. The Pharmaceutical segment is focused on six immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism and pulmonary hypertension. The Medical Devices segment includes a range of products used in the interventional solutions, orthopedic, surgery, and vision fields.
Open
Prior close
Today's high
Today's low
52 Week high
52 Week low
PRNewsWire • 1 day ago • JNJ
Earlier use of CARVYKTI® demonstrated lasting treatment-free remissions at 2.5 years in patients with relapsed or refractory multiple myeloma
PRNewsWire • 1 day ago • JNJ
Johnson & Johnson's INLEXZO™ (gemcitabine intravesical system) delivers 74 percent disease-free survival at one year in BCG-unresponsive, high-risk, papillary-only NMIBC
Zacks Investment Research • 2 days ago • JNJ
Johnson & Johnson (JNJ) Stock Drops Despite Market Gains: Important Facts to Note
24/7 Wall Street • 3 days ago • JNJ
The Dividend Stocks That Keep Paying Even When Markets Stumble
Zacks Investment Research • 3 days ago • JNJ
3 Large Drug Stocks to Watch as the Industry Shows Some Recovery
Charts and pricing are provided for informational purposes only. The current market data is delayed up to 15 minutes. The accuracy of any market data displayed is not guaranteed.